Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?

1 week ago 7

Abdul Rahman

Mon, June 22, 2026 astatine 9:14 AM CDT 2 min read

Insmed Incorporated (NASDAQ:INSM) is one of the astir promising healthcare stocks according to Wall Street analysts. On June 10, Cantor Fitzgerald reaffirmed its Overweight standing connected Insmed Incorporated (NASDAQ:INSM) and raised its terms people from $230 to $235.

Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald's Target Raise?

Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?

The steadfast pointed to an upcoming information merchandise for Insmed's experimental lung cause TPIP arsenic a imaginable catalyst that investors whitethorn beryllium underestimating. TPIP, which stands for Treprostinil Palmitil Inhalation Powder, is an inhaled therapy Insmed is processing for pulmonary arterial hypertension (PAH).

According to Cantor Fitzgerald, it has been astir a twelvemonth since Insmed archetypal presented the Phase 2b objective proceedings results for TPIP successful PAH. The steadfast sees the adjacent information merchandise arsenic a infinitesimal that could meaningfully revive capitalist involvement successful the drug. This information is simply a one-year unfastened statement hold update expected successful Q3 2026. For context, an unfastened statement hold is the signifier of a objective survey wherever each patients are fixed the existent cause and monitored implicit a longer period, and the information from this signifier typically gives a clearer representation of however durable and harmless the attraction is implicit time.

The steadfast noted that if the adjacent information merchandise provides robust results, the marketplace whitethorn displacement absorption from Brinsupri, Insmed's cause for non-cystic fibrosis bronchiectasis. This is due to the fact that the marketplace is importantly undervaluing TPIP conscionable due to the fact that Brinsupri posted blowout gross astatine the extremity of Q1 2026.

Insmed Incorporated (NASDAQ:INSM) is simply a biopharmaceutical company. It focuses connected processing and commercializing therapies for superior and uncommon diseases. One of its pb approved merchandise is ARIKAYCE, an inhaled antibiotic delivered via the Lamira Nebulizer System.

While we admit the imaginable of INSM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 High-Growth Micro-Cap Stocks to Buy Now and 10 Best Long-Term Stocks to Invest In According to Bill & Melinda Gates Foundation Trust.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article